Gyrodyne (NASDAQ:GYRO) Shares Cross Below 200 Day Moving Average – What’s Next?

Gyrodyne , LLC (NASDAQ:GYRO)’s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $7.12 and traded as low as $5.40. Gyrodyne shares last traded at $5.4050, with a volume of 6,552 shares traded.

Gyrodyne Trading Down 0.5%

The business has a 50-day moving average of $5.77 and a 200-day moving average of $7.10.

Institutional Investors Weigh In On Gyrodyne

An institutional investor recently bought a new stake in Gyrodyne stock. Susquehanna International Group LLP acquired a new stake in shares of Gyrodyne , LLC (NASDAQ:GYRO) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 14,186 shares of the real estate investment trust’s stock, valued at approximately $142,000. Susquehanna International Group LLP owned approximately 0.65% of Gyrodyne as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 71.36% of the company’s stock.

Gyrodyne Company Profile

Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.